SGCG and cancer: The present study has demonstrated that the elevation of Th2 subset in patients with stage I cancer as compared with healthy subjects or patients with cholecystolithiasis suggests that the tumor-bearing state may induce a switch from a Th1-type to a Th2-type cytokine profile, although further research is necessary.